unknown
Stage
1
Investors
About
Herasight develops advanced genetic screening tools for embryos, using whole genome technologies and polygenic risk scoring to help prospective parents assess and reduce disease risks during IVF.
Explore Herasight's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.